Lundbeck chief executive resigns amid scandal
November 25, 2014Medical Communications, Sales and Marketing Björklund, Lundbeck, stratified medical, ulf wiinberg
Ulf Wiinberg has resigned from his chief executive post at Denmark-based pharma giant Lundbeck following a beach of its rules …
Virgo Consumer Health promotes to senior team
November 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo, natasha weeks, rebecca rhodes
Virgo has promoted its long-standing employee Natasha Weeks (pictured) to the position of director and lead of its Consumer Health …
CHMP nods several drugs through
November 24, 2014Sales and Marketing Boehringer, CHMP, EMA, Esbriet, FDA, Sanofi, nintedanib, ofev
Ten new medicines have been recommended for approval by the EMA’s Committee for Medicinal Products for Human Use (CHMP), among …
Takeda: we’re working on Ebola too
November 24, 2014Research and Development, Sales and Marketing Ebola, GSK, Gates, Obama, WHO, brett wells, pharmafile, rajeev, vaccines, venkaya, venkayya
The president of Takeda Vaccines has told Pharmafile that the Japanese firm has identified compounds that could help prevent infection …
Antibiotics: will the industry saviour please stand up
November 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Antibiotics, EAA, MRC, WHO, resistance, susie lunt
The spectre of a new ‘dark ages’ for humanity where common infections begin to kill again is increasingly making itself …
New managing director for Napp Pharmaceuticals
November 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Napp, alberto, martinez
Alberto Martinez has joined Napp Pharmaceuticals in the UK as its new managing director, taking over the role from Dietmar …
ABPI: NHS must change to allow stratified drugs
November 21, 2014Research and Development, Sales and Marketing ABPI, NHS, george freeman, personalised, rawal, stratified medicines
The development of stratified medicines – especially in therapy areas outside of oncology – will have a significant effect on …
Future bleak for Novartis’ myeloma drug
November 21, 2014Medical Communications FDA, Farydak, Novartis, ixazomib, myeloma, panobinostat
Novartis suffered a major disappointment with the negative FDA panel vote for multiple myeloma candidate Farydak earlier this month, but …
Ablynx looks to GSK for new chief commercial officer
November 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, johan heylan
Belgium-based biopharma firm Ablynx has appointed Johan Heylen to be its chief commercial officer and assume responsibility for all commercial …
Global drug spending set to top $1 trillion
November 20, 2014Sales and Marketing Gilead, IMS, Kadcyla, Perjeta, drugs, hepatitis C, sovaldi, spend
Worldwide spending on drugs will reach over $1 trillion in 2014 and $1.3 trillion by 2018, according to a new …
Gilead gets Harvoni boost for Europe
November 20, 2014Sales and Marketing EU, Gilead, HCV, harvoni, hepc, ledipasvir, sofosbuvir, svaldi
Gilead Sciences’ new hepatitis C (HCV) tablet Harvoni has been approved across the European Union to treat the majority of …
Sanofi showcases alirocumab at AHA
November 20, 2014Sales and Marketing Amgen, PCSK9, Regeneron, Sanofi, aha, alirocumab, evolocumab
Sanofi and Regeneron released a battery of new Phase III data on their PCSK9 inhibitor alirocumab this week, reinforcing the …
NICE aims for earlier cancer diagnosis
November 20, 2014Sales and Marketing Cancer, England, NHS, NICE, OECD, UK, baker
NICE is updating its guidance in a bid to help doctors spot the signs and symptoms of cancer as part …
Sanofi names new board member
November 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, bonnie bassler
Sanofi has appointed Professor Bonnie Bassler as an independent member to sit among its board of directors. Bassler has more …
GSK tests mHealth trial solutions
November 19, 2014Medical Communications, Sales and Marketing Apple, GSK, Medidata, dr Vries, healthpatch, mhealth
GlaxoSmithKline is experimenting with mobile health (mHealth) devices linked to cloud services in clinical trials as part of a bid …
AZ predicts strong growth ahead of Pfizer deadline
November 19, 2014Sales and Marketing AZD9291, AstraZeneca, Pfizer, Soriot, definiens
AstraZeneca has announced that it expects to deliver revenues of over $45 billion by 2023 as it makes its final …
Reckitt finalises pharmaceutical demerger plans
November 19, 2014Business Services, Sales and Marketing Reckitt Benckiser Pharmaceuticals, cillit bang, indivior, suboxone
Reckitt Benckiser has confirmed its plans to spin-off its pharmaceutical portfolio from its core consumer products business. Final details of …
Europe must prepare for COPD ‘timebomb’
November 19, 2014Sales and Marketing COPD, Europe, European COPD Coalition, Spiriva, asthma, chronic obstructive pulmonary disease
Health services in Europe are not making sufficient effort to cope with the escalating burden of chronic obstructive pulmonary disease …
NICE wants more Xolair data
November 19, 2014Sales and Marketing Genentech, NHS, NICE, Novartis, UK, Xolair, hives, omalizumab
Novartis has been asked in draft guidance to give NICE more information before the watchdog can recommend its veteran asthma …
Sanofi appoints an Ebola response co-ordinator
November 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ebola, Sanofi, gary nobel
Former director of the NIH Vaccine Research Center Dr Gary Nabel has been hired by Sanofi to spearhead its contribution …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
